drugset / Trial / NCT00855920
Study Utilizing Rilonacept in Gout Exacerbations
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This purpose of this clinical research was to determine the efficacy and safety of an experimental drug called Rilonacept in participants with an acute gout attack. Participants participated in this study for 30 days. Rilonacept alone was being compared with Indomethacin alone and the combination of Rilonacept plus Indomethacin in treating acute gout flares.
Timeline
- Start
- 2009-03
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Indomethacin | Small molecule | 25 mg | Oral |
| Comparator | Rilonacept | Protein / enzyme biologic | 320 mg | Subcutaneous |